相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: CATALYTIC RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: NUCLEAR HORMONE RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling
Xing Huang et al.
EMBO JOURNAL (2013)
Autophagy induced by cathepsin S inhibition induces early ROS production, oxidative DNA damage, and cell death via xanthine oxidase
Chien-Chang Huang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Autophagy Controls p38 Activation to Promote Cell Survival under Genotoxic Stress
Lei Qiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MIR376A Is a Regulator of Starvation-Induced Autophagy
Gozde Korkmaz et al.
PLOS ONE (2013)
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
A. W. Tolcher et al.
ANNALS OF ONCOLOGY (2012)
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
Yan-Fang Tao et al.
BMC CANCER (2012)
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma
Bruce D. Cheson et al.
CANCER (2012)
The survivin suppressants NSC 80467 and YM155 induce a DNA damage response
Trevor G. Glaros et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
Takahito Nakahara et al.
ANTI-CANCER DRUGS (2011)
Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells
Qinwen Wang et al.
CANCER LETTERS (2011)
Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
Takahito Nakahara et al.
CANCER SCIENCE (2011)
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Karl D. Lewis et al.
INVESTIGATIONAL NEW DRUGS (2011)
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
T. Iwasa et al.
BRITISH JOURNAL OF CANCER (2010)
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity
Euphemia Leung et al.
CANCER BIOLOGY & THERAPY (2010)
p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
Ashish Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh et al.
CLINICAL CANCER RESEARCH (2009)
Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells
Tsuyoshi Minematsu et al.
DRUG METABOLISM AND DISPOSITION (2009)
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer
Giuseppe Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bcl-2 family members - Dual regulators of apoptosis and autophagy
Beth Levine et al.
AUTOPHAGY (2008)
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Autophagy is activated for cell survival after endoplasmic reticulum stress
Maiko Ogata et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Autophagy: Dual roles in life and death?
EH Baehrecke
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
An IAP-IAP complex inhibits apoptosis
T Dohi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities:: implications for β-amyloid peptide over-production and localization in Alzheimer's disease
WH Yu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
E Devarajan et al.
ONCOGENE (2002)
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing
Y Kabeya et al.
EMBO JOURNAL (2000)
The lysosomotropic agent monodansylcadaverine also acts as a solvent polarity probe
A Niemann et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
分享论文
